Anticoagulants and cancer survival.

Piccioli A, Falanga A, Prandoni P.

Semin Thromb Hemost. 2006;32(8):810-3.

Cancer and venous thromboembolism.

Piccioli A, Falanga A, Baccaglini U, Marchetti M, Prandoni P.

Semin Thromb Hemost. 2006;32(7):694-9.

Venous thromboembolism and cancer: guidelines of the Italian Association of Medical Oncology (AIOM).

Mandalà M, Falanga A, Piccioli A, Prandoni P, Pogliani EM, Labianca R, Barni S; working group AIOM.

Crit Rev Oncol Hematol. 2006;59(3):194-204.

Differential effect of the low-molecular-weight heparin, dalteparin, and unfractionated heparin on microvascular endothelial cell hemostatic properties.

Vignoli A., Marchetti M., Balducci D., Barbui T., Falanga A.

Haematologica. 2006;91(5):620.

The extension of disease is associated to an increased risk of venous thromboembolism (VTE) in patients with gastrointestinal (GI) carcinoma.

Mandalà M, Falanga A, Cremonesi M, Zaccanelli M, Floriani I, Viganò MG, Rosti A, Cazzaniga ME, Ferretti G, Cabiddu M, Barni S.

Thromb Haemost. 2006;95(4):752-4.